Optometry News

CooperVision’s Generation Sight initiative, which “signifies a transformative commitment” to providing myopia management for underserved children, has enrolled its first participants, the company announced in a press release.

BOSTON — Annual exams with topography are key to identifying progression in patients with keratoconus regardless of whether they have undergone cross-linking, according to a speaker here.

“If you think it’s expensive to hire a professional to do the job, wait until you hire an amateur.”

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Greg Kunst, CEO of Aurion Biotech, discusses the company’s cell therapy for corneal endothelial disease.

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Pete England, vice president of global marketing at ViaLase, discusses the company’s femtosecond laser platform for the treatment of open-angle glaucoma.

After my dad got cataract surgery with monofocal IOLs aimed for plano, he wasn’t supposed to be able to read without glasses. And yet, to his utter delight, he could.

BOSTON — Despite the unpredictability that comes with new product launches and reimbursement issues, experts are hopeful about ophthalmic business prospects in 2024.

Both full-field and virtual bioptic telescope magnification modes on head-mounted display devices significantly helped improve reading ability among patients with low vision, according to a study published in Optometry and Vision Science.

Melt Pharmaceuticals secured $24 million in Series B preferred stock financing from new and existing investors, according to a press release.

Patients with presbyopia achieved visual acuity improvement with LNZ100 in the phase 3 CLARITY safety and efficacy trials, according to a press release from Lenz Therapeutics.